A reverse genetics-based NS1-truncated live attenuated vaccine confers broad heterologous protection against swine influenza viruses
Microbial Pathogenesis · 2026-09 · 218 · 108638
DOI: 10.1016/j.micpath.2026.108638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2026-09. Verfasst von Fengjun Xiang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Animal Infectious Diseases and Molecular Immunology, College of Animal Science and Technology, Guangxi University, Nanning, 530004, PR …. Hauptthemen laut MEDLINE: Influenza Vaccines, Orthomyxoviridae Infections, Viral Nonstructural Proteins, Swine Diseases. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Guangxi Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Swine influenza A viruses (swIAVs) undergo frequent reassortment and evolution, posing significant threats to both animal and human health. In this study, we employed reverse genetics to generate five recombinant viruses and evaluated their potential as vaccine candidates. Through pathogenicity evaluation in mice, we identified two promising candidates: an inactivated vaccine (rPR8-JGL16+2) and a live-attenuated vaccine (rPR8-JGL15+3). Both vaccines induced robust hemagglutination inhibition (HI) antibody responses and specific IgG levels against homologous strains. Notably, the attenuated rPR8-JGL15+3 vaccine provided complete protection against both homologous (H1N1) and heterologous (H3N2) viral challenges, with no detectable viral loads in the lungs or nasal turbinate. Although the inactivated rPR8-JGL16+2 vaccine exhibited effective protective efficacy against influenza viruses, it did not fully inhibit the replication of heterologous viruses in mice. Histopathological assessment revealed that rPR8-JGL15+3 immunization prevented significant lung damage, contrasting with the mild pathology observed in rPR8-JGL16+2-vaccinated animals. These findings demonstrate the successful development of novel vaccine candidates against avian-like H1N1 swIAV, with the attenuated vaccine showing promise for broad protection against circulating strains.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Animal Infectious Diseases and Molecular Immunology, College of Animal Science and Technology, Guangxi University, Nanning, 530004, PR China.
- Guangxi Nongken Yongxin Animal Husbandry Group Jinguang Co., Ltd., Nanning, 530042, PR China.
- Laboratory of Animal Infectious Diseases and Molecular Immunology, College of Animal Science and Technology, Guangxi University, Nanning, 530004, PR China; Guangxi Zhuang Autonomous Region Engineering Research Center of…
Förderung
- Guangxi Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Xiang, F., Xu, Y., Liu, C., Li, X., Wang, R., Zhang, H., Dong, S., Huang, J., Luo, T., Qin, Y., Ouyang, K., Yin, Y., Wei, Z., Huang, W., & Chen, Y. (2026). A reverse genetics-based NS1-truncated live attenuated vaccine confers broad heterologous protection against swine influenza viruses. Microbial Pathogenesis, 218, 108638. https://doi.org/10.1016/j.micpath.2026.108638
Vancouver
Xiang F, Xu Y, Liu C, Li X, Wang R, Zhang H, et al. A reverse genetics-based NS1-truncated live attenuated vaccine confers broad heterologous protection against swine influenza viruses. Microbial Pathogenesis. 2026;218:108638. doi:10.1016/j.micpath.2026.108638
BibTeX
@article{Xiang2026,
author = {Xiang, Fengjun and Xu, Yi and Liu, Changyun and Li, Xiaolong and Wang, Rang and Zhang, Haodong and Dong, Shanshan and Huang, Jiamo and Luo, Tingting and Qin, Yifeng and Ouyang, Kang and Yin, Yeshi and Wei, Zuzhang and Huang, Weijian and Chen, Ying},
title = {A reverse genetics-based NS1-truncated live attenuated vaccine confers broad heterologous protection against swine influenza viruses},
journal = {Microbial Pathogenesis},
year = {2026},
volume = {218},
pages = {108638},
doi = {10.1016/j.micpath.2026.108638}
}
EUVIMED